Harout Semerjian, President and CEO at Geron Corporation, shared a post on LinkedIn:
“Welcome Pat and Constantine to the Geron Board of Directors. Looking forward to working with you!”
Quoting Geron Corporation’s post:
“We are pleased to welcome Constantine Chinoporos and Pat Andrews to our Board of Directors.
They are proven biopharmaceutical industry leaders, and their deep operational expertise, particularly with commercial-stage organizations, will be instrumental in building a leading, sustainable hematology company.”
Other Articles Featuring Harout Semerjian on OncoDaily.